Literature DB >> 25500541

Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.

A A Bhat1, J L Pope1,2, J J Smith3, R Ahmad1, X Chen4, M K Washington5, R D Beauchamp3,6,7, A B Singh3,4, P Dhawan1,3,6.   

Abstract

In normal colon, claudin-7 is one of the highly expressed claudin proteins and its knockdown in mice results in altered epithelial cell homeostasis and neonatal death. Notably, dysregulation of the epithelial homeostasis potentiates oncogenic transformation and growth. However, the role of claudin-7 in the regulation of colon tumorigenesis remains poorly understood. Using a large colorectal cancer (CRC) patient database and mouse models of colon cancer, we found claudin-7 expression to be significantly downregulated in cancer samples. Most notably, forced claudin-7 expression in poorly differentiated and highly metastatic SW620 colon cancer cells induced epithelial characteristics and inhibited their growth in soft agar and tumor growth in vivo. By contrast, knockdown of claudin-7 in HT-29 or DLD-1 cells induced epithelial-to-mesenchymal transition (EMT), colony formation, xenograft-tumor growth in athymic mice and invasion. Importantly, a claudin-7 signature gene profile generated by overlapping the DEGs (differentially expressed genes in a high-throughput transcriptome analysis using claudin-7-manipulated cells) with human claudin-7 signature genes identified high-risk CRC patients. Furthermore, Rab25, a colon cancer suppressor and regulator of the polarized cell trafficking constituted one of the highly upregulated DEGs in claudin-7 overexpressing cells. Notably, silencing of Rab25 expression counteracted the effects of claudin-7 expression and not only increased proliferation and cell invasion but also increased the expression of p-Src and mitogen-activated protein kinase-extracellular signal-regulated kinase 1/2 that were suppressed upon claudin-7 overexpression. Of interest, CRC cell lines, which exhibited decreased claudin-7 expression, also exhibited promoter DNA hypermethylation, a modification associated with transcriptional silencing. Taken together, our data demonstrate a previously undescribed role of claudin-7 as a colon cancer suppressor and suggest that loss of claudin-7 potentiates EMT to promote colon cancer, in a manner dependent on Rab25.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25500541      PMCID: PMC4804637          DOI: 10.1038/onc.2014.385

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

1.  Loss of RAB25 expression in breast cancer.

Authors:  Ji-Ming Cheng; Ming Ding; Ahmed Aribi; Prabodh Shah; Krishna Rao
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

2.  Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells.

Authors:  Mercedes Lioni; Patricia Brafford; Claudia Andl; Anil Rustgi; Wafik El-Deiry; Meenhard Herlyn; Keiran S M Smalley
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  EMT: when epithelial cells decide to become mesenchymal-like cells.

Authors:  Raghu Kalluri
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

4.  Cancer prevention: epigenetics steps up to the plate.

Authors:  Jean-Pierre Issa
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-19

5.  Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.

Authors:  Patrick T Caswell; Heather J Spence; Maddy Parsons; Dominic P White; Katherine Clark; Kwai Wa Cheng; Gordon B Mills; Martin J Humphries; Anthea J Messent; Kurt I Anderson; Mary W McCaffrey; Bradford W Ozanne; Jim C Norman
Journal:  Dev Cell       Date:  2007-10       Impact factor: 12.270

6.  Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus.

Authors:  Yu Usami; Hideki Chiba; Fumihito Nakayama; Junya Ueda; Yoshiko Matsuda; Norimasa Sawada; Takahide Komori; Akihiko Ito; Hiroshi Yokozaki
Journal:  Hum Pathol       Date:  2006-05       Impact factor: 3.466

7.  DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma.

Authors:  Stéphanie Boireau; Michael Buchert; Michael S Samuel; Julie Pannequin; Joanne L Ryan; Armelle Choquet; Héliette Chapuis; Xavier Rebillard; Christophe Avancès; Matthias Ernst; Dominique Joubert; Nicolas Mottet; Frédéric Hollande
Journal:  Carcinogenesis       Date:  2006-07-08       Impact factor: 4.944

8.  Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.

Authors:  Sheng-Ru Shiou; Amar B Singh; Krishnan Moorthy; Pran K Datta; M Kay Washington; R Daniel Beauchamp; Punita Dhawan
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

9.  Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.

Authors:  Gregory M Sheehan; Bhaskar V S Kallakury; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Journal:  Hum Pathol       Date:  2007-02-15       Impact factor: 3.466

10.  Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma.

Authors:  Fumihito Nakayama; Shuho Semba; Yu Usami; Hideki Chiba; Norimasa Sawada; Hiroshi Yokozaki
Journal:  Pathobiology       Date:  2008       Impact factor: 4.342

View more
  41 in total

1.  Proliferation-independent regulation of organ size by Fgf/Notch signaling.

Authors:  Agnė Kozlovskaja-Gumbrienė; Ren Yi; Richard Alexander; Andy Aman; Ryan Jiskra; Danielle Nagelberg; Holger Knaut; Melainia McClain; Tatjana Piotrowski
Journal:  Elife       Date:  2017-01-13       Impact factor: 8.140

2.  Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells.

Authors:  Ajaz A Bhat; Rizwan Ahmad; SrijayaPrakash B Uppada; Amar B Singh; Punita Dhawan
Journal:  Exp Cell Res       Date:  2016-10-11       Impact factor: 3.905

Review 3.  Claudin proteins, outside-in signaling, and carcinogenesis.

Authors:  Amar B Singh; Srijayaprakash B Uppada; Punita Dhawan
Journal:  Pflugers Arch       Date:  2016-12-17       Impact factor: 3.657

4.  Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric.

Authors:  Jason T George; Mohit Kumar Jolly; Shengnan Xu; Jason A Somarelli; Herbert Levine
Journal:  Cancer Res       Date:  2017-09-25       Impact factor: 12.701

Review 5.  Claudins in morphogenesis: Forming an epithelial tube.

Authors:  Amanda I Baumholtz; Indra R Gupta; Aimee K Ryan
Journal:  Tissue Barriers       Date:  2017-08-24

6.  Testing the gene expression classification of the EMT spectrum.

Authors:  Dongya Jia; Jason T George; Satyendra C Tripathi; Deepali L Kundnani; Mingyang Lu; Samir M Hanash; José N Onuchic; Mohit Kumar Jolly; Herbert Levine
Journal:  Phys Biol       Date:  2019-01-18       Impact factor: 2.583

Review 7.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 8.  Inducing stable reversion to achieve cancer control.

Authors:  Scott Powers; Robert E Pollack
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

9.  Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue.

Authors:  Lei Ding; Liyong Wang; Leiming Sui; Huanying Zhao; Xiaoxue Xu; Tengyan Li; Xiaonan Wang; Wenjing Li; Ping Zhou; Lu Kong
Journal:  J Hum Genet       Date:  2016-04-28       Impact factor: 3.172

10.  Severe Intestinal Inflammation in the Small Intestine of Mice Induced by Controllable Deletion of Claudin-7.

Authors:  Wen-Jing Li; Chang Xu; Kun Wang; Teng-Yan Li; Xiao-Nan Wang; Hui Yang; Tiaosi Xing; Wen-Xia Li; Yan-Hua Chen; Hong Gao; Lei Ding
Journal:  Dig Dis Sci       Date:  2018-02-27       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.